Health ❯Healthcare
Vaccination Infectious Diseases Epidemiology Disease Prevention Health Policy Vaccines Medicaid NHS Disease Outbreaks Pandemic Response
Novartis will roll out the cherry-flavored, dissolvable therapy largely at cost after Ghana’s authorization with approvals expected from eight other African regulators within 90 days.